Literature DB >> 20559516

Hereditary colon cancer: lynch syndrome.

Eunjeong Jang1, Daniel C Chung.   

Abstract

Lynch syndrome is the most common familial colorectal cancer syndrome. It is linked to germline mutations in one of four DNA mismatch repair (MMR) genes. A comprehensive family history is one important way to identify at-risk individuals. The elucidation of the molecular genetics of this syndrome has made it possible to screen for the disorder with molecular tests. Microsatellite instability and/or immunohistochemistry followed by germline testing for mutations in MMR genes is now a standard approach for clinically suspected cases. Correctly recognizing Lynch syndrome is essential for the application of appropriate screening and surveillance measures. Close surveillance and risk-reducing operations can decrease cancer-related mortality. In addition, counseling is an important component of the management of any family with Lynch syndrome.

Entities:  

Keywords:  Colon cancer; Hereditary nonpolyposis colon cancer; Immunohistochemistry; Lynch syndrome; Microsatellite instability; Mismatch repair gene

Year:  2010        PMID: 20559516      PMCID: PMC2886941          DOI: 10.5009/gnl.2010.4.2.151

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  41 in total

1.  Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study.

Authors:  Mark A Jenkins; Marina E Croitoru; Neerav Monga; Sean P Cleary; Michelle Cotterchio; John L Hopper; Steven Gallinger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

2.  Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.

Authors:  Fay Kastrinos; Elena M Stoffel; Judith Balmaña; Ewout W Steyerberg; Rowena Mercado; Sapna Syngal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

Review 3.  Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians.

Authors:  Yvonne M C Hendriks; Andrea E de Jong; Hans Morreau; Carli M J Tops; Hans F Vasen; Juul Th Wijnen; Martijn H Breuning; Annette H J T Bröcker-Vriends
Journal:  CA Cancer J Clin       Date:  2006 Jul-Aug       Impact factor: 508.702

4.  Feasibility of screening for Lynch syndrome among patients with colorectal cancer.

Authors:  Heather Hampel; Wendy L Frankel; Edward Martin; Mark Arnold; Karamjit Khanduja; Philip Kuebler; Mark Clendenning; Kaisa Sotamaa; Thomas Prior; Judith A Westman; Jenny Panescu; Dan Fix; Janet Lockman; Jennifer LaJeunesse; Ilene Comeras; Albert de la Chapelle
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

Review 5.  Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.

Authors:  Noralane M Lindor; Gloria M Petersen; Donald W Hadley; Anita Y Kinney; Susan Miesfeldt; Karen H Lu; Patrick Lynch; Wylie Burke; Nancy Press
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

6.  MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome.

Authors:  Vishes Chhibber; Karen Dresser; Meera Mahalingam
Journal:  Mod Pathol       Date:  2007-12-07       Impact factor: 7.842

7.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.

Authors:  Leigha Senter; Mark Clendenning; Kaisa Sotamaa; Heather Hampel; Jane Green; John D Potter; Annika Lindblom; Kristina Lagerstedt; Stephen N Thibodeau; Noralane M Lindor; Joanne Young; Ingrid Winship; James G Dowty; Darren M White; John L Hopper; Laura Baglietto; Mark A Jenkins; Albert de la Chapelle
Journal:  Gastroenterology       Date:  2008-05-02       Impact factor: 22.682

Review 8.  Genomic and epigenetic instability in colorectal cancer pathogenesis.

Authors:  William M Grady; John M Carethers
Journal:  Gastroenterology       Date:  2008-09-04       Impact factor: 22.682

9.  The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.

Authors:  Patrice Watson; Hans F A Vasen; Jukka-Pekka Mecklin; Inge Bernstein; Markku Aarnio; Heikki J Järvinen; Torben Myrhøj; Lone Sunde; Juul T Wijnen; Henry T Lynch
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

10.  Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

Authors:  Johanne Geary; Peter Sasieni; Richard Houlston; Louise Izatt; Ros Eeles; Stewart J Payne; Samantha Fisher; Shirley V Hodgson
Journal:  Fam Cancer       Date:  2007-10-16       Impact factor: 2.375

View more
  14 in total

1.  Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome.

Authors:  Miguel Serrano; Pedro Lage; Sara Belga; Bruno Filipe; Inês Francisco; Paula Rodrigues; Ricardo Fonseca; Paula Chaves; Isabel Claro; Cristina Albuquerque; António Dias Pereira
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

2.  Performance of Lynch syndrome predictive models in quantifying the likelihood of germline mutations in patients with abnormal MLH1 immunoexpression.

Authors:  Verónica Cabreira; Carla Pinto; Manuela Pinheiro; Paula Lopes; Ana Peixoto; Catarina Santos; Isabel Veiga; Patrícia Rocha; Pedro Pinto; Rui Henrique; Manuel R Teixeira
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

3.  An Evaluation of the Fecal Microbiome in Lynch Syndrome.

Authors:  Adalberto Gonzalez; Nikhil Kapila; Jose Melendez-Rosado; Hong Liang; Fernando Castro-Pavia
Journal:  J Gastrointest Cancer       Date:  2021-01-25

Review 4.  Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists.

Authors:  Malak Itani; Neeraj Lalwani; Dhakshinamoorthy Ganeshan; Maria Zulfiqar; Cary Siegel
Journal:  Abdom Radiol (NY)       Date:  2021-04-13

5.  Pediatric Colorectal Carcinoma: A Series of Seven Cases.

Authors:  Nidhi Mahajan; Harshita Agarwal; Chhabi Ranu Gupta; Mamta Sengar; Arti Khatri; Niyaz Khan
Journal:  J Indian Assoc Pediatr Surg       Date:  2022-05-12

6.  Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer.

Authors:  Marilyn Huang; Tegan Hunter; Lydia A Fein; Johnny Galli; Sophia George; Matthew Schlumbrecht; Kelly McCarter; Abdulrahman K Sinno; Luiz P Guido; Andre Pinto
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

7.  Feasibility of Utilizing PREMM Score for Lynch Syndrome Identification in an Urban, Minority Patient Population.

Authors:  Brigid Adviento; Michael Conner; Alexander Sarkisian; Nicolette Walano; Hans Andersson; Jordan Karlitz
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

8.  The association of low penetrance genetic risk modifiers with colorectal cancer in lynch syndrome patients: a systematic review and meta-analysis.

Authors:  Neil Donald; Salim Malik; Joshua L McGuire; Kevin J Monahan
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

9.  Hypermutagenesis in untreated adult gliomas due to inherited mismatch mutations.

Authors:  Jason K Sa; Seung Won Choi; Junfei Zhao; Yeri Lee; Jing Zhang; Doo-Sik Kong; Jung Won Choi; Ho Jun Seol; Jung-Il Lee; Antonio Iavarone; Raul Rabadan; Do-Hyun Nam
Journal:  Int J Cancer       Date:  2019-01-07       Impact factor: 7.396

10.  Metastatic colorectal carcinoma mimicking primary ovarian carcinoma presenting as 'giant' ovarian tumors in an individual with probable Lynch syndrome: a case report.

Authors:  Peter A Ongom; Michael Odida; Robert L Lukande; Josephat Jombwe; Emmanuel Elobu
Journal:  J Med Case Rep       Date:  2013-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.